A Zebrafish Model of Roberts Syndrome Reveals That Esco2 Depletion Interferes with Development by Disrupting the Cell Cycle by Mönnich, Maren et al.
A Zebrafish Model of Roberts Syndrome Reveals That
Esco2 Depletion Interferes with Development by
Disrupting the Cell Cycle
Maren Mo ¨nnich
1, Zoe ¨ Kuriger
1, Cristin G. Print
2, Julia A. Horsfield
1*
1Department of Pathology, Dunedin School of Medicine, The University of Otago, Dunedin, New Zealand, 2Department of Molecular Medicine and Pathology, School of
Medical Sciences, and the Bioinformatics Institute, The University of Auckland, Auckland, New Zealand
Abstract
The human developmental diseases Cornelia de Lange Syndrome (CdLS) and Roberts Syndrome (RBS) are both caused by
mutations in proteins responsible for sister chromatid cohesion. Cohesion is mediated by a multi-subunit complex called
cohesin, which is loaded onto chromosomes by NIPBL. Once on chromosomes, cohesin binding is stabilized in S phase upon
acetylation by ESCO2. CdLS is caused by heterozygous mutations in NIPBL or cohesin subunits SMC1A and SMC3, and RBS is
caused by homozygous mutations in ESCO2. The genetic cause of both CdLS and RBS reside within the chromosome
cohesion apparatus, and therefore they are collectively known as ‘‘cohesinopathies’’. However, the two syndromes have
distinct phenotypes, with differences not explained by their shared ontology. In this study, we have used the zebrafish
model to distinguish between developmental pathways downstream of cohesin itself, or its acetylase ESCO2. Esco2
depleted zebrafish embryos exhibit features that resemble RBS, including mitotic defects, craniofacial abnormalities and
limb truncations. A microarray analysis of Esco2-depleted embryos revealed that different subsets of genes are regulated
downstream of Esco2 when compared with cohesin subunit Rad21. Genes downstream of Rad21 showed significant
enrichment for transcriptional regulators, while Esco2-regulated genes were more likely to be involved the cell cycle or
apoptosis. RNA in situ hybridization showed that runx1, which is spatiotemporally regulated by cohesin, is expressed
normally in Esco2-depleted embryos. Furthermore, myca, which is downregulated in rad21 mutants, is upregulated in
Esco2-depleted embryos. High levels of cell death contributed to the morphology of Esco2-depleted embryos without
affecting specific developmental pathways. We propose that cell proliferation defects and apoptosis could be the primary
cause of the features of RBS. Our results show that mutations in different elements of the cohesion apparatus have distinct
developmental outcomes, and provide insight into why CdLS and RBS are distinct diseases.
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Introduction
The cohesin complex is best known for its crucial function in
mediating sister chromatid cohesion during the cell division cycle.
Cohesin comprises four core subunits: structural maintenance of
chromosomes (SMC) subunits Smc1 and Smc3, plus two non-
SMC subunits, Mcd1/Scc1/Rad21, and Scc3/Stromalin (SA).
The leading theory for establishment of cohesion is that cohesin
forms a large molecular ring that entraps sister DNA strands [1].
The loading of cohesin onto chomosomes and the subsequent
establishment of cohesion are separate events. Loading of cohesin
onto chromosomes takes place in telophase in most organisms, and
is facilitated by a protein complex containing Scc2 (Nipped-B in
Drosophila and NIPBL in human) and Scc4/MAU-2 [2,3,4]. Once
loaded, cohesin exhibits marked differences in residence time on
chromosomes, indicating that not all cohesin is stably bound [5,6].
It is thought that the more stably bound fraction of cohesin has
functions in addition to chromosome cohesion, including regulat-
ing gene expression [5].
During S phase, stably bound cohesin is converted to a ‘cohesive’
form by interaction with the DNA replication machinery [7,8,9], in
association with an acetyltransferase known as Ctf7/Eco1 in yeast,
and Esco2 in vertebrates [9,10,11]. Esco2 acetylates cohesin subunit
Smc3 to generate the cohesive form of cohesin, essential for holding
sister chromatids together through G2 until M phase [12,13,14].
This cohesive form of cohesin has a long-term residency on
chromosomescommensuratewith thestably bound cohesin fraction
[5]. Esco2 also appears to antagonize the activity of a cohesion
disestablishment complex containing Pds5 and Wapl [15,16]. Thus,
Esco2 is an important factor in ensuring cohesion persists between
sister chromatids until their separation at anaphase.
At anaphase, the Rad21 subunit of cohesin is cleaved by the
protease separase, and the cohesin ring is opened, allowing
chromosomes to separate [17]. The Smc3 subunit of cohesin can
be recycled onto chromosomes at the next cell cycle, but
deacetylation of Smc3 by class I histone deacetylase Hos1 is
required before this can happen [18,19,20]. Thus, deacetylation
by Hos1 opposes Esco29s acetylation activity.
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break repair. For double strand breaks to be effectively repaired,
the cohesive form of cohesin must be established at the location of
the break [21]. Stabilization of cohesin at double strand breaks
depends on acetylation of the Rad21 subunit by Esco2, plus
antagonism of the disassociation complex containing Wapl [22].
Since 2004, it has emerged that human developmental
syndromes arise from mutations in proteins responsible for sister
chromatid cohesion. Inactivating mutations in ESCO2 cause
Roberts Syndrome/SC Phocomelia (RBS/SC) [23,24,25,26].
RBS is characterized by severe growth deficiency, microcephaly,
craniofacial abnormalities and mental retardation. SC phocomelia
is much milder with less marked limb reduction and survival to
adulthood. Both disorders arise from ESCO2 mutations with no
apparent genotype/phenotype correlation [25,26]. Since the exact
same ESCO2 mutation can cause Roberts or SC Phocomelia, it
has been proposed that both be termed Roberts Syndrome, which
would then cover the entire spectrum of pathology [26].
Chromosomes from RBS/SC patients are characterized by
precocious sister chromatid separation, particularly at heterochro-
matic regions of the chromosomes [23,25]. Cornelia de Lange
Syndrome (CdLS), on the other hand, is caused by haploinsuffi-
ciency for NIPBL or by missense mutations in the SMC1A or SMC3
cohesin subunits [27]. CdLS patients display diverse and highly
variable mental deficits and structural abnormalities [28,29,30,31].
In contrast to RBS/SC, chromosome cohesion defects are not
associated with CdLS [32]. Despite their shared ontogeny within
the sister chromatid cohesion apparatus, RBS/SC and CdLS are
distinct syndromes. Nevertheless, they have been grouped into a
category of human developmental syndromes known as ‘cohesi-
nopathies’.
There is strong evidence that CdLS is caused by altered
expression of developmental genes, rather than by cell cycle
anomalies (reviewed in [32,33,34]). In Drosophila, mouse and
zebrafish models analyzing Nipbl or cohesin depletion, specific
gene expression changes were observed that were not associated
with cell cycle or chromosome cohesion defects [34,35,36,37].
Transcript profiling of lymphoblastoid cell lines from CdLS
patients also identified consistent gene expression alterations [38].
Genome-scale mapping of cohesin binding sites provides further
evidence that it directly regulates transcription. In Drosophila,
Nipped-B and cohesin co-localize genome-wide, and associate
preferentially with active genes [39,40]. Furthermore, it was
recently demonstrated that cohesin directly regulates the expres-
sion of a number of genes in Drosophila salivary glands in which
endoreduplicating chromosomes do not separate, showing defin-
itively that cohesin regulation of gene expression is entirely
separable from its role in the cell cycle [41].
In vertebrates, cohesin appears to regulate gene expression in
combination with specific transcriptional regulators, such as
CTCF [42,43,44,45], mediator complex [46] and estrogen
receptor alpha [47]. The favoured model is that gene regulation
by cohesin occurs through its mediation of long-range enhancer-
promoter communication [46,48]. It is thought to be the stable
fraction of cohesin that functions in regulating gene expression [5].
It is not known if the acetyltransferase activity of Esco2 contributes
to stabilizing cohesin for this function.
Our previous research indicated specific roles for cohesin in
regulating gene expression during zebrafish development. We
found that cohesin is expressed in both proliferating and non-
proliferating cells in the zebrafish embryo [49] and is required for
early tissue-specific transcription of runx1 and runx3 during
embryogenesis [36]. Furthermore, cohesin is required for
transcription of myca, the zebrafish c-Myc ortholog [37].
Cohesin’s role in developmental gene expression is thought to
contribute to the pathology of CdLS [27,50]. It is not known how
ESCO2 activity influences gene expression to contribute to RBS.
In this study, we have again used the zebrafish model, to
determine if Esco2 contributes to the same developmental
pathways that operate downstream of cohesin activity. Esco2-
depleted zebrafish embryos recapitulated many of the phenotypes
observed in RBS, including limb (fin) truncations and craniofacial
abnormalities. However, we found that, in contrast to loss of
Rad21 [37], Esco2 depletion does not result in a strong signature
of developmental gene misregulation. Of the few genes regulated
in common in response to Esco2 and Rad21 depletion, most were
involved in the cell cycle and apoptosis. Furthermore, myca, runx1
and runx3, which are all tissue-specifically regulated by cohesin,
were not regulated in the same direction in Esco2-depleted
embryos; in fact, myca was upregulated. Esco2 embryos exhibited a
cell cycle block in G2 and strong upregulation of caspase activity,
regardless of p53 function.
We suggest that the phenotype caused by Esco2 depletion is
primarily due to a paucity of cells resulting from cell death
following G2 arrest, and not by the regulation of developmental
genes. Our research indicates that although the cohesinopathies
arise from mutations in a related family of proteins, individual
syndromes within the cohesinopathies can have distinct molecular
etiology.
Results
Identification and expression pattern of zebrafish esco2
in zebrafish embryo development
Sequence information on the zebrafish esco2 gene, on
chromosome 20, was available in Ensembl (END-
SARG00000014685) and NCBI (Gene ID: 445395). The
zebrafish esco2 transcript is 2350 base pairs long and encodes
609 amino acids. Its identity was confirmed by comparison with
other Esco2 sequences (Fig. S1), which revealed that zebrafish
Esco2 is 41% identical to the human and mouse proteins (NCBI
BLAST). Phylogenetic analysis grouped zebrafish Esco2 together
with Esco2 proteins from other species, closest to the Atlantic
salmon (Salmo salar)w i t hXenopus laevis as the next closest relative
(Fig. S2A). A chromosomal location comparison with mouse and
human (Fig. S2B) shows conserved gene synteny of esco2 between
these species.
Considering their related functions, we first asked if zebrafish
esco2 is expressed in the same cells as cohesin during embryo
development. To determine spatiotemporal expression of the esco2
gene, a riboprobe of the esco2 gene was hybridized with zebrafish
embryos collected at intervals up to 4 days post-fertilization (dpf).
esco2 expression was ubiquitous in early development (data not
shown), however from about 24 hours post-fertilization (hpf),
specific patterns of esco2 transcript distribution were observed.
From 24–48 hpf, esco2 was expressed in the brain ventricles and
otic vesicles (Fig. 1A–E). From 36–48 hpf, esco2 is expressed faintly
in the developing pectoral fin (Fig. 1B, C) and in a layer of retinal
cells (Fig. 1B–E). At 36 hpf, expression of esco2 was detected in the
mid-hindbrain boundary and hindbrain proliferative zone, and in
the branchial arches (Fig. 1B, C). At 4 dpf, robust esco2 expression
was detected in the developing pharynx, the gut and the heart
(Fig. 1F). In summary, the expression pattern of esco2 during
zebrafish embryo development closely resembles that of cohesin
subunits [49], and is predominantly found in proliferative cells.
This is consistent with the finding that Esco2 is important for the
establishment of sister chromatid cohesion in conjunction with
cohesin.
Esco2 Loss Impairs Development by Cell Cycle Block
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reduced pectoral fin growth
Zebrafish embryos were used to evaluate the consequences of
Esco2 depletion on early development. We used antisense
morpholino oligonucleotides (MOs) targeting the ATG start codon
(esco2_ATG_MO), or the 59 donor of the exon/intron boundary of
intron 2 of esco2 (esco2_Splx2_MO), to create knockdown
‘‘morphant’’ embryos. RT-PCR amplification of cDNA demon-
strated marked reduction in splicing of intron 2 from esco2 mRNA
in esco2_Splx2_MO-injected embryos (Fig. S2C), generating an
aberrant transcript predicted to lead to early termination of the
Esco2 protein. Both MOs elicited identical phenotypes in zebrafish
embryos. However, a higher dose of esco2_Splx2_MO was needed
to generate equivalent effects to esco2_ATG_MO (data not shown),
perhaps reflecting that the latter MO targets both maternally
deposited spliced mRNA as well as zygotically transcribed mRNA.
For this reason, esco2_ATG_MO (henceforth termed esco2 MO for
simplicity) was used for all subsequent experiments.
When compared with wild type controls, esco2 morphants had
smaller eyes and a smaller head at 24 hpf, accompanied by
noticeable cell death in the brain (Fig. 2A, B). Somites formed
normally but were incorrectly shaped, and there was dorsal
curvature of the tail with a thin yolk sac extension. Reduced p53
function modestly rescued morphological abnormalities in 24 hpf
esco2 morphants (Fig. 2C, D). At 72 hpf, esco2 morphants were
slightly smaller than wild type embryos. They had a smaller head
that essentially lacked a jaw, showed an abnormal pigmen-
tation pattern, and had reduced blood with circulation defects
(Fig. 2E, F). Cardiac and cerebral edema became pronounced at
this stage. None of the observed phenotypes was rescued by
reduction in p53 function (Fig. 2D, H); in fact, reduction of
functional p53 enhanced the esco2 morphant phenotype (Figs. 2H
and S2). esco2 morphant embryos failed to develop beyond 72 hpf,
were highly edemic, and rarely survived beyond this time point.
To gain insight into the craniofacial phenotypes observed in
RBS, we wished to observe the effects of esco2 depletion on
cartilage and bone development. To do this, it was necessary to
reduce the MO dose to produce hypomorphic esco2 morphants to
allow for cartilage development. esco2 ‘‘hypomorphants’’ can
survive past 72 hpf without the formation of cardiac edema, which
might in itself contribute to cartilage malformation. These more
mildly affected embryos started to recover after 3 days of
development due to the dilution of the morpholino during
development, and survived to at least 7 days. esco2 hypomorphants
displayed disorganized craniofacial cartilage with underdeveloped
jaw elements, as revealed by Alcian Blue staining. In esco2
hypomorphants, the ceratohyal arch was oriented ventrally rather
than forwards, and ceratobranchial arches 3–6 were reduced in
size compared with wild type (Fig. 2I, J, K, L). Ceratobranchial
arches 5 and 6 were severely reduced in length and were barely
visible with Alcian Blue staining (Fig. 2M, N). Furthermore, the
more distal arches were kinked towards anterior at their
extremities. The basal element of arch 2 (basihyal of hyoid) was
present, but shaped differently in esco2 hypomorphants than wild
type embryos. Hypobranchials were thinner and elongated in esco2
hypomorphants. In the affected craniofacial cartilage elements, the
cell numbers were reduced and cell size was enlarged. In some
embryos, gaps in the anterior basicranial commissure could be
detected (Fig. 2O), as well as additional cell structures protruding
from a cartilage element (Fig. 2P).
Alizarin Red was used to stain for bone formation in esco2
hypomorphants at 7 dpf. Ossification appeared to be essentially
normal in Esco2-depleted embryos (Fig. 2Q, R). The shape of
ossified structures was altered relative to wild type, presumably
because of the misdevelopment of cartilage in esco2 hypomorphants.
These data suggest that craniofacial malformations caused by
loss of Esco2 could be due to loss and mispositioning of cartilage,
or the incorrect migration of neural crest cells that contribute to
craniofacial development. Our analysis of the expression of genes
that mark migrating neural crest, sox10 and crestin, showed that
these genes are essentially expressed normally in esco2 morphants
(Fig. S3A–D). However, the accumulation of pigment cells (Fig. 2F)
in esco2 morphants together with truncated distribution of crestin at
16 somites (Fig. S3A, C) suggests that while neural crest cells are
specified, they may not be migrating to form the craniofacial
cartilage. The cranial neural crest marker dlx2a was expressed
normally at early stages (Fig. S3E, H), but altered and reduced
expression in the pharyngeal arches and forebrain at 24 hpf
(Fig. S3F, G, I, J) indicates that dlx2-expressing cells may be
inefficiently located to these tissues.
A defining characteristic of RBS is tetraphocomelia [26],
therefore we were interested to determine the effects of Esco2
Figure 1. Late embryonic and larval expression of esco2 in zebrafish. Whole-mount in situ hybridization of zebrafish at the indicated stage
with an esco2 antisense riboprobe. A, B, and D are dorsal views, C, E, and F lateral views. Anterior is to the left for all. ov, otic vesicle; epz, eye
proliferative zone; pf, pectoral fin; t, tectum; mhb, mid-hindbrain boundary; hpz, hindbrain proliferative zone; ba, branchial arches; p, pharynx;
h, heart; g, gut.
doi:10.1371/journal.pone.0020051.g001
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pectoral fin was abnormally shaped and severely reduced in
length when compared with wild type (Fig. 3A, E; B, F). Fin
reduction in esco2 morphants was enhanced when the function of
p53 was reduced (data not shown). Interestingly, in esco2
hypomorphants, pectoral fin growth was retarded at first, until
around 3 dpf, when presumably, the esco2 MO becomes too
diluted to retain its effect. At this stage, the fins appear to display
catch-up growth (Fig. 3C, G). Strikingly, by 6 dpf, cells appeared
to be dividing more actively in the developing fins of esco2
hypomorphants than in wild type embryos (Fig. 3D, H). Our
interpretation is that the affected structures appear to compensate
for an early paucity of cells by accelerating proliferation once
Esco2 levels start to recover. The data suggest that fin stunting is
not due to a patterning defect caused by loss of Esco2, but rather
by inadequate cell numbers.
Figure 2. Craniofacial development is abnormal in esco2 morphants. A–D, At 24 hpf, esco2 morphants (B) had a smaller head, smaller eyes
and noticeable cell death in the head region compared to wild type (A), and could be partially rescued by depletion of p53 (p53
2/2, C, D). E–H,A t7 2
hpf esco2 morphants lacked a jaw and showed an abnormal pigmentation pattern (arrows) (F compared with E, wild type). The phenotype was
enhanced by depletion of p53 (G, H). A–H, lateral views of live larvae, anterior to the left. I–P, Craniofacial cartilage was stained with Alcian Blue (AB)
at 6 dpf. A low dose of esco2 MO was injected to allow for cartilage development (esco2 MO low). Numbers of the pharyngeal arch elements are
indicated (2–7). I, J, Ventral views. K, L, lateral views. Pharyngeal arch elements were malformed or missing in esco2 morphants (J, L) compared to wild
type (I, K). M, N, closer views of dissected pharyngeal arch elements in wild type (M) and esco2 morphant (N). The arrows point to the kinks in arches 3
and 4. The asterisks mark elongated hypobranchials (hb) in an esco2 morphant. O, closer view of anterior basicranial commissure (abc) in an esco2
morphant, where a gap in the structure was observed (arrowhead). P, closer view of the neurocranium with additional cell structures (arrowhead) at
the base of the trabeculae (t) in an esco2 morphant. Q, R, Alizarin Red (AR) staining of bone matrix at 7 dpf (ventral views) revealed that ossification is
normal in an esco2 morphant (R, compare to wild type in Q). The close-ups show branchial arch 7. ch, ceratohyal; bh, basihyal; hb, hypobranchial;
cb, ceratobranchial; abc, anterior basicranial commissure; t, trabeculae; ep, ethmoid plate.
doi:10.1371/journal.pone.0020051.g002
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Loss of craniofacial cartilage and fin stunting in esco2 morphants
could be due to a lack of cell proliferation or cell death in these
tissues. To determine the effects of Esco2 depletion on the cell
cycle, we labeled S phases with BrdU, M phases with anti-
phosphohistone H3 and apoptotic cells with TUNEL. Surprising-
ly, we found that the number of cells in S phase in esco2 morphants
was roughly equivalent to wild type, indicating that entry into S
phase was not compromised by Esco2 depletion (Fig. 4A–E). In
contrast, the number of cells in mitosis was significantly increased
in esco2 morphants compared with wild type (Fig. 4F–J). Confocal
microscopy revealed that most mitotic cells in esco2 morphants had
distorted spindles, and disorganized chromosomes that were
scattered through the cell (Fig. 4P–R). These data indicate that
in esco2 morphants, cells become blocked at the onset of mitosis,
which is consistent with the role identified for Esco2 in establishing
chromosome cohesion. TUNEL assays indicate high levels of
apoptosis in esco2 morphants (Fig. 4K–O). Apoptotic cells were
particularly prevalent throughout the brain, peripheral nervous
system and the eyes of esco2 morphants. The data are consistent
with the idea that S phase entry occurs normally in esco2
morphants, but subsequently, cells are unable to proceed through
mitosis and die by apoptosis, which probably reflects the activation
of G2 and/or spindle assembly checkpoints in cells of these
embryos.
Apoptosis in esco2 morphants is associated with caspase
activation, but is independent of p53
To determine if apoptosis in esco2 morphants is p53-dependent,
we injected the esco2 MO into embryos homozygous for p53
M214K,
a genetic background that leads to compromized p53 function. In
the p53
M214K line, activation of p53 response genes is absent,
therefore p53-dependent apoptosis should not be induced [51,52].
In this p53-deficient background, cells in S phase were similar
between esco2-depleted and wild type embryos at 24 hpf (Figs. 5A
and S4A–D). However, there was a slight increase of S phases in
esco2 morphants in the p53-deficient background at day 2 (Figs. 5B
and S4E–H). This may indicate that intact p53 retards re-entry of
damaged esco2-depleted cells into the cell cycle. Apoptosis in the
p53 mutant background was just as prevalent as that observed on a
wild type background (Figs. 5B and S4I–N). Thus, apoptosis in
esco2 morphants appears to be independent of p53.
One p53-independent pathway for apoptosis is activation of
DEATH receptors followed by signaling through caspase 8.
Microarray analysis (see below) showed that casp8 mRNA levels
were dramatically increased in esco2 morphants. To find out if this
apoptotic pathway is responsible for the cell death observed in
esco2 morphants, we analyzed morphant embryos for the activity of
specific caspases. We found a 2–3 fold enhancement in the
activities of caspase 8 (Fig. 5C) and caspases 3 and 7 (Fig. 5E) in
24 hpf esco2 morphants. By comparison, the activity of these
caspases was raised 7–10 fold in 24 hpf rad21 mutants (Fig. 5E, F).
rad21 mutants are more severely affected than esco2 morphants at
this stage, which could account for this difference. At 2 dpf, only
caspases 3/7 remained elevated in esco2 morphants (Fig. 5E
compared with C). The raised caspase activities indicate that
caspase-dependent apoptotic programs are indeed activated in
esco2 morphants. The drop in caspase 8 activity by day 2 could
indicate that initiation of apoptosis occurs within the first day of
Esco2-depleted development.
Together, the data suggest that a paucity of cells in Esco2-
depleted embryos is due to increased cell death following a mitotic
blockade and activation of DEATH receptor signaling. Because
we observed pectoral fin recovery in esco2 hypomorphants, it is
possible that cell death alone could cause the craniofacial and
pectoral fin phenotypes. However, it is also possible that these
developmental phenotypes are due to the misregulation of
developmental genes downstream of esco2. Since the related
cohesinopathy CdLS is characterized by changes in developmental
gene expression, and Esco2 is important for cohesin function, we
went on to investigate this possibility.
Gene regulation downstream of Esco2 has minimal
overlap with cohesin-dependent transcription
Several groups have now shown that cohesin has an important
role in the regulation of developmental genes [53,54,55]. We had
Figure 3. Pectoral fin development is impaired in esco2 morphants. A, B, E, F, The pectoral fin was shorter and abnormally shaped in esco2
morphants. Fins of wild type (A) and morphant (E) live embryos at 3 dpf (dorsal view). Flat-mounted pectoral fins at 2.5 dpf were smaller and less
structured in esco2 morphants (F) compared with wild type (B). C, G, D, H, Alcian Blue staining revealed catch-up growth in pectoral fins at 6 dpf. The
fins of esco2 morphants (G) were comparable to wild type (C) in size and overall structure. Closer views of cell structure in pectoral fins at 6 dpf
showed that cells in esco2 morphant embryos (H) were smaller and more condensed compared to evenly shaped and similar sized cells in wild type
(D), perhaps indicating rapid cell divisions in the morphants.
doi:10.1371/journal.pone.0020051.g003
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early zebrafish through microarray analysis of a null mutation in
the zebrafish rad21 gene (rad21
nz171) [37]. This analysis revealed
that, in addition to genes involved in the cell cycle, genes involved
in transcription and development were regulated downstream of
Rad21 [37].
To determine if genes that have altered expression as a result of
Esco2 depletion are similar to those regulated downstream of
Rad21, we collected RNA from 24 hpf and 48 hpf esco2 morphants
and control embryos, and prepared probes that were hybridized to
Affymetrix microarrays. Following normalisation and statistical
analysis using linear models (LIMMA; false discovery rate of 5%
and |fold change|$2), differential expression of several transcripts
between morphant and wild type embryos was observed,
particularly at 24 hpf. Gene Ontology analysis was performed
using the GATHER web tool with the 24 hpf differentially
abundant transcript lists. This analysis indicated that at 24 hpf, the
RNAs differentially expressed in esco2 morphants were enriched
for RNAs involved in cell proliferation and apoptosis:
(GO:008283, ccng1, ccng2, cdc6, cdca7, ctbp1, cyr61, dut, erbb2, erbb4,
fgb, fgg, fhit, fhit1, fth1, irf1, mcm2, mcm3, mdm2, mdm4, nck1, plk3,
prdx1, rps27, sesn3, tp53, tsga2). Consistent with this cell cycle
profile, differentially expressed genes were also enriched for targets
of the cell cycle associated transcription factor complex E2F-1:DP-
1. However, most of the RNAs that were differentially expressed in
the esco2 morphants did not fall into any particular functional
category. At 48 hpf, no significant functional pathways emerged
from differentially regulated transcripts in esco2 morphants
compared with controls. The data suggest that the transcriptional
response to Esco2 depletion happens early, and involves primarily
cell cycle regulators along with other RNAs encoding proteins of
mixed function.
Figure 4. Cell cycle is blocked at mitosis in esco2 morphants. A–E, Cells in S phase stained with BrdU were similar in numbers in wild type
(A, B) and esco2 morphant (C, D). Statistical analyses did not show a significant difference in cell numbers in the tails of embryos at 2 dpf (E). F–J, pH3
staining of mitotic cells revealed increased cell numbers in esco2 morphant (H, I) compared to wild type (F, G). The difference in cell numbers is
statistically significant (J). K–O, Apoptotic cells labeled with TUNEL were severely increased in esco2 morphants (M, N, compared to wild type in K, L).
The difference in cell numbers is statistically significant (O). Lateral views of 2 dpf larval heads (A, F, K, C, H, M) and regions in tail above the yolk sac
extension (B, G, L, D, I, N), anterior to the left. An asterisk in the graphs (J, O) indicates a statistically significant difference in cell numbers of esco2
morphants compared with wild type embryos (p-value,0.05). P–R, Confocal images of mitotic cells at 1 dpf stained with anti-a-tubulin (red) and
counterstained with DAPI (blue, left panels). Right panels: merged images. In esco2 morphants the DNA was fragmented (P, Q, left panels) and
spindles were often disorganized (R, right panel) compared to wild type (P). Scale bar: 5 mm.
doi:10.1371/journal.pone.0020051.g004
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analysis of rad21
nz171 mutants [37], very few of the proliferation-
and transcription-associated RNAs affected by Rad21 inactiva-
tion were also affected by Esco2-depletion, as indicated by the
difference in numbers of colored nodules in the graphs in Figure
S5. Taken together the data indicate that, unlike cohesin, Esco2
is probably not directly involved in the transcriptional regulation
of developmental and cell cycle genes, at least, not by the same
mechanism.
Regulation of myca and runx genes by cohesin is not
Esco2-dependent
We previously demonstrated that a network of genes related to
myca (zebrafish c-Myc), mdm2 and p53 is regulated downstream of
Rad21, and that cohesin directly binds the transcription start sites
of myca, mdm2, and p53 [37]. To test whether these genes are
similarly regulated downstream of Esco2, we used quantitative
PCR to evaluate their expression in esco2 morphants at 24 and
48 hpf. Consistent with the microarray results, p53 and mdm2 were
Figure 5. Caspase activity is increased in esco2 morphants and rad21 mutants. A, Numbers of S phase cells detected by BrdU labeling were
similar in esco2 morphants and wild type at 1 and 2 dpf. Additional depletion of p53 significantly increased S phase entry in esco2 morphants at 2 dpf
(asterisk). B, Apoptotic cells labeled with TUNEL were significantly increased in esco2 morphants compared with wild type at 1 and 2 dpf. Additional
depletion of p53 did not rescue the observed apoptosis. Asterisks indicate where a significant difference in cell numbers was observed in esco2
morphants compared with wild type and the p53 mutant. C, Caspase 8 activity in esco2 morphants was increased at 1 dpf, but not at 2 dpf compared
to wild type control. D, Caspase 8 activity was severely increased in rad21 mutants (rad21 mut) at 1 dpf compared to siblings (rad21 sibs). E, Caspase
3/7 activity was increased in esco2 morphants at 1 dpf and 2 dpf. F, Caspase 3/7 activity was severely increased in rad21 mutants at 1 dpf.
doi:10.1371/journal.pone.0020051.g005
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(Fig. 6A, B). Surprisingly myca, which is strongly downregulated in
cohesin-depleted embryos [37], was upregulated up to 2-fold in
esco2 morphants (Fig. 6C, compared to a 1.4-fold increase of myca
mRNA in the microarray Fig. S5B). This unexpected finding was
confirmed by in situ hybridization analysis of myca expression in
whole mount zebrafish embryos. Compared with wild type, a
much higher abundance of myca transcript was detected in the eyes
and brain of 24 and 48 hpf esco2 morphants (Fig. 6D–K). The
reason for myca upregulation is not known, but it may be part of a
mechanism to compensate for excess cell death in esco2 morphants
(Figs. 4, 5).
The developmental transcription factors runx1 and runx3 are
regulated by cohesin in a tissue-specific manner [36], so we sought
to determine whether these genes are similarly regulated in esco2
morphants. In situ hybridization revealed no change in expression
of these genes in esco2 morphants at the developmental stages in
which they are regulated by cohesin (Fig. S6, and data not shown).
Therefore we conclude that cohesin-dependent regulation of myca,
runx1 and runx3 does not depend on Esco2 activity.
Together, the results suggest that while there is good evidence
that cohesin’s regulation of developmental genes could contribute
to CdLS, there appears to be no equivalent role for gene
regulation by ESCO2 in RBS. If ESCO2 does directly contribute
to transcription, it is likely to do so by a distinct mechanism.
Discussion
While several groups have used animal models to understand
the biology of CdLS [34,35,56,57], to date there have been no
animal models investigating the pathological basis of RBS. Our
study in zebrafish represents the first such example of an animal
model. In this study, we have used zebrafish to show that the
molecular etiology of RBS is distinct from CdLS.
We found that Esco2 depleted zebrafish embryos exhibit similar
phenotypes to humans with RBS [25,26,58,59,60]. Esco2-depleted
fish have craniofacial abnormalities characterized by missing
cartilaginous elements (Fig. 2). They have truncated pectoral fins
(Fig. 3), much like the phocomelia observed in RBS patients. Cells
in Esco2 morphants exhibited mitotic defects characterized by
disorganized chromosomes spread throughout the cell (Fig. 4).
This observation is consistent with precocious sister chromatid
separation observed in cells from RBS patients [60].
Cell death was the most striking phenotype observed in Esco2
morphants (Figs. 4, S4). In the first day of development, Esco2-
depleted embryos upregulated genes required for apoptosis,
activated cell death pathways and exhibited high numbers of
apoptotic cells through the brain and peripheral nervous system
(Figs. 4K–O, 5B, C, E; 6A, B; S4). This phenotype was not
unexpected, since lack of chromosome cohesion would be certain
to activate the spindle assembly checkpoint.
Our results raise the possibility that cell death, rather than
defects in patterning, cause dysmorphology upon Esco2 depletion.
Pectoral fin growth recovers via a spurt of ‘‘catch-up’’ proliferation
in embryos treated with a low dose of esco2 MO (Fig. 3). This
finding strongly suggests that fin stunting in esco2 morphants is not
caused by a patterning defect, and that the underlying limb
developmental pathways are unaffected. Ossification is normal in
esco2 morphants (Fig. 2Q, R), further indicating that the
developmental pathways giving rise to bone are intact in these
embryos.
The lack of jaw elements in esco2 morphants could be due to cell
death in that region, or defects in cell migration from neural crest
to form the cartilaginous structures in the jaw. Cells of neural crest
Figure 6. Cell cycle control genes are severely affected in esco2 morphants. A–C, qPCR at 1 and 2 dpf showing significantly increased mRNA
abundance in esco2 morphants of p53 (A) and mdm2 (B), and increased mRNA levels of myca (C). D–K, In situ hybridization with a myca probe at 24
hpf and 48 hpf. Note the strong expression in the eyes of esco2 morphants (H) compared with wild type (D) and the abnormal expression in the brain
(I compared with wild type in E) at 24 hpf. At 48 hpf myca expression seemed to be slightly increased in the brain of esco2 morphants (J, K compared
with wild type in F, G) but was expressed in a normal pattern. D, H, F, J, lateral views, E, I, G, K, dorsal views. Anterior is to the left.
doi:10.1371/journal.pone.0020051.g006
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Markers of neural crest show that these cells are specified normally
in esco2 morphants (Fig. S3). A truncated pattern of crestin
expression (Fig. S3A, C) and accumulation of patches of pigment
in esco2 morphants (Fig. 2F) suggests that although neural crest
contributors to pharyngeal arch development are specified, there
may be a problem with their migration to form elements of the
craniofacial skeleton (Fig. 2I–P). Alternatively, precursor cells may
be lost due to apoptosis, and thereby lose the opportunity to
migrate. Interestingly, cell death, cell migration defects and jaw
structure loss were found upon mutation of another chromatin
modifying factor, phf8 [62]. Perhaps Esco2 is involved in histone
modification pathways similar to Phf8, or alternatively, both
phenotypes may reflect cell death in the developing embryo.
It was previously shown that developmental defects arise with
abnormalities in cell proliferation, or an increase in cell death, as
the sole cause. For example, an X-irradiation driven chick model
of phocomelia showed that loss of proximal structures is caused by
a time-dependent loss of skeletal progenitors, and not by a
patterning defect [63]. Phocomelia is a consistent feature of RBS,
and our zebrafish data support the idea that this feature need not
be due to patterning defects.
It has often been argued that cohesinopathies arise from
changes in developmental gene expression that result from
cohesin’s role in gene regulation. Previous work has shown that
several genes are up- and down- regulated in response to cohesin
loss [35,37,38,40,64]. Changes in developmental gene expression
downstream of cohesin are thought to contribute to the pathology
of CdLS [50]. A similar function for ESCO2 in causing RBS has
not yet been identified. Our microarray data demonstrated that
few specific developmental pathways are co-ordinately regulated
downstream of Esco2, and that the regulated RNAs in esco2
morphants are primarily involved in apoptosis and the cell cycle.
These results are in sharp contrast with those obtained previously
in rad21
nz171 mutants, where dense networks of cell cycle-
associated RNAs emerged [37] (Fig. S5). The transcriptional
regulators runx1, runx3 and myca genes are all positively regulated
by cohesin in zebrafish [36,37], but are not regulated by Esco2 in
the same direction (Figs. 6C–K, S6 and data not shown). In fact,
myca is upregulated upon Esco2 depletion (Fig. 6C–K), possibly to
compensate for reduced proliferation. Importantly, while the loss
of acetyltransferase activity of Esco2 can cause RBS [24], it is not
required for the regulation of cohesin-dependent genes. Thus, the
cohesin acetylating activity of Esco2 can be separated from any
other role it might have in regulating transcription. If Esco2 is
responsible for direct regulation of gene expression, it probably
does so independently of cohesin.
Although we found that few of the RNAs were regulated by
cohesin disruption (outside of those involved in the cell cycle and
apoptosis) were also regulated by Esco2 disruption, there were
notable exceptions. One of these was ascl1, a Notch-responsive
gene that promotes neuronal differentiation [65]. Interestingly,
Ascl1/Mash1 was found to be one of only three factors needed to
convert fibroblasts into neuronal progenitors [66]. We found that,
in addition to being downregulated upon Esco2 depletion, ascl1
expression is exquisitely sensitive to the gene dose of rad21 [37]
and it is also downregulated on depletion of zebrafish Nipbl (M.M.
and J.A.H., unpublished data). This raises the possibility that there
are additional, as yet unknown pathways downstream of cohesion
proteins linking cell proliferation with differentiation.
In summary, our results indicate that the molecular pathology
underlying RBS is unlikely to involve the regulation of
developmental genes, at least not by similar mechanisms to those
proposed for CdLS. This draws into question the use of
‘‘cohesinopathies’’ to describe a class of syndromes with a similar
genetic etiology, but distinct developmental pathologies.
Materials and Methods
Zebrafish lines
Zebrafish were maintained as described previously [67]. All
zebrafish research was approved by the University of Otago
Animal Ethics Committee (approval #07/54).
Microinjection
Antisense morpholino oligonucleotides were obtained from
GeneTools LLC. For microinjection, 2 nl of morpholino solution
diluted in Danieau’s buffer was injected into the yolk of wild type
embryos at the 1 to 2-cell stage. Morpholino sequences and effective
amounts were esco2_ATG_MO, 59-CTCTTTCGGGATAACAT-
CTTCAATC-39 (0.175-0.25 pmol) and esco2_splx2_MO, 59-GTA-
AACTACACAATGTTACCTCTCG-39 (0.75-1.25 pmol).
In situ hybridization and morphological analysis
A 1120 bp long fragment of esco2 (accession number
NM_001003872) was amplified with 59-AGCAGGGACCTTC-
TACAGCA-39 forward and 59-GGGATCATCTGGAAGAAC-
GA-39 reverse primers, and cloned into the pGEM-Teasy vector
(Promega) for riboprobe synthesis. The plasmid was linearized with
SacII (Roche) and transcribed with SP6 RNA polymerase (Roche).
In situ hybridization was performed as described previously [68].
Cartilage and bone was stained with Alcian Blue and Alizarin Red,
respectively, as described previously [69].
Cell cycle analysis and immunohistochemistry
Bromodeoxyuridine (BrdU) incorporation was performed on
whole embryos as described previously [70]. Mouse monoclonal
anti-BrdU antibody (Roche) was detected using a Vectastain ABC
Kit (Vector Laboratories). Phosphorylated histone H3 was
detected as described previously using an anti-Phospho-Histone
H3 (Ser10) antibody (Cell Signaling), followed by detection with
anti-rabbit-HRP (Sigma) [70]. TUNEL staining was performed
using the ApopTag Kit (Chemicon) as described previously [70].
Cell counts were done on images of a defined region of the tail of 3
embryos each. The cell number of the wild type was set to 100%.
To statistically compare cell counts between the samples, a two-
sided t-test was used. Spindle morphology in mitotic cells was
analyzed on whole embryos with anti-a-tubulin (Sigma), and anti-
rabbit-TRITC (Sigma) antibodies as previously described [70].
DNA was counterstained with DAPI (Invitrogen), embryos
mounted in Vectashield (Vector laboratories) and analyzed by
confocal microscopy (Zeiss LSM 510).
Quantitative RT-PCR
Total RNA from pools of 50 embryos was extracted using
Trizol, DNAse-treated, and used to synthesize random-primed
cDNA (SuperScriptIII, Invitrogen). SYBR Green PCR Master
Mix (Applied Biosystems) was used to amplify cDNA, and relative
quantities were normalized to b-actin and wnt5a expression.
Samples were analyzed using an Applied Biosystems 7300 Real-
Time PCR System. Quantitative PCR primer sequences for mdm2,
p53 and mcya were reported previously [37].
Caspase assays
Single cell suspensions were generated in triplicates of
25 embryos at the desired stage by mashing and filtering in
PBS/10% NCS through cell strainers (100 mm, BD Falcon). Cells
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Caspase-Glo 8 and Caspase-Glo 3/7 Assays (Promega) according
to the manufacturer’s instructions. To reduce non-specific
background activity in the Caspase 8 assay, the provided inhibitor
MG-132 (Promega) was used according to the manufacturer’s
instructions. Luminescence was measured after 75 minutes on a
Synergy 2 multi-detection microplate reader (BioTek Instruments,
Inc.). Protein concentration was assessed using a BCA Protein
Assay Kit and a BSA standard (Pierce) according to the
manufacturer’s instructions and was similar in all samples (not
shown).
Microarray and analysis
Total RNA was extracted from 4 replicates (50 embryos each) of
24 hpf and 48 hpf esco2_ATG morphants and control embryos
(injected with buffer only) using Trizol (Invitrogen) and purified
using Qiagen RNeasy columns. RNA integrity was measured using
the Agilent Bioanalyzer 2100 (RIN $9.5 for all samples).
Hybridization to GeneChip Zebrafish Genome Arrays (Affymetrix)
and data acquisition were performed at The University of Otago
Genomics Facility. All microarray data is MIAME compliant and
the raw data has been deposited in GEO, accession number
GSE27569. Analysis was performed using the statistical framework
‘R’ (http://cran.r-project.org/). All microarrays passed quality
control using the AffyQCreport package. Data were normalized
using the RMA method and differential RNA abundance identified
using LIMMA. The thresholds for the generation of lists of
differentially expressed RNAs were chosen after observation of
heatmaps, and the false discovery rate was controlled at 5% using
the Benjamini and Hochberg method, with the additional criteria
that |mean linear fold change|$2. Gene sets were tested for
enrichment of particular functional categories using the GATHER
web tool (http://gather.genome.duke.edu/) with Bayes Factor
cutoff $5 and p#0.05, as well as using the Ingenuity Pathways
Analysis software (http://www.ingenuity.com/).
Supporting Information
Figure S1 Multiple sequence alignment of Esco2 se-
quences. Protein sequences of human, mouse and zebrafish were
aligned using the ClustalW program (www.ebi.ac.uk/clustalw/;
Chenna et al., 2003, PubMedID: 12824352). Accession numbers
for sequences used are Homo sapiens Q56NI9.1, Mus musculus
Q8CIB9.3, and Danio rerio Q5SPR8.1.
(TIF)
Figure S2 Evolutionary conservation and knock down of
zebrafish esco2. A, Cladograms of Esco1 and Esco2 proteins.
Cladograms were constructed using Geneious Pro 4.6.2 software.
Accession numbers for protein sequences are S. cerevisiae CAY79478,
D. melanogaster AAF50579, for Esco2: D. rerio Q5SPR8, S. salar
ACI33242, X. laevis BAF91194, G. gallus XP_420012, M. musculus
Q8CIB9, R. norvegicus XP_002725161, H. sapiens Q56NI9, P. troglodytes
XP_001164762, B. taurus NP_001094652, A. melanoleuca XP_00291-
4478, and for Esco1: X. laevis ADP44706, M. musculus Q69Z69, R.
norvegicus AAI66441, M. mulatta XP_001091733, P. troglodytes XP_52-
3883, H. sapiens Q5FWF5, A. melanoleuca XP_002928389, E. caballus
XP_001491308, S. scrofa XP_003127900, B. taurus DAA15944. B,
Conserved synteny of the zebrafish esco2 gene when compared with
human and mouse. Databases: Ensembl Danio rerio version 59.8
(Zv8), Ensembl Homo sapiens version 59.37d (GRCh37), and
Ensembl Mus musculus version 59.37l (NCBIM37). C,T h e
esco2_splx2_MO inhibits splicing of the second intron. Primers
spanning intron 2 were used to detect splice blocking. cDNA,
complementary DNA; control, no reverse transcriptase; WT, cDNA
from uninjected embryos; MO, cDNA from esco2_splx2_MO-
injected embryos; gDNA, genomic DNA where amplification product
size is identical to the unspliced transcript.
(TIF)
Figure S3 Some neural crest and developmental mar-
kers are expressed in a slightly abnormal pattern in
esco2 morphants. A, C, Crestin expression at the 16 somite stage.
Crestin expressing cells at the anterior side were more condensed in
esco2 morphants (C, arrows) than wild type (A). B, D, Sox10
expression was normal in esco2 morphants at the 15 somite stage (D,
comparedtowild typeinB).E–J,Dlx2aexpressionat16somiteswas
normal in esco2 morphants (H, compared to wild type in E). At 24
hpf expression of dlx2a was slightly reduced in the branchial arches
and the forebrain of esco2 morphants (I, compared to F). The close-
ups on the forebrain show an abnormal dlx2a distribution in esco2
morphants (J, compared to wild type in G).
(TIF)
Figure S4 Apoptosis in esco2 morphants is independent
of p53. A–H, BrdU-labeled proliferating cells at 24 hpf (A–D) and
48 hpf (E–H). Proliferation was normal in esco2 morphants (B, F,
compare to wild type in A, E). Additional depletion of p53 in the
p53
M214K mutant line (p53
2/2, C, G) led to increased prolifer-
ation at 48 hpf (H), but not 24 hpf (D). I–N, TUNEL staining of
apoptotic cells at 24 hpf (I, J) and 48 hpf (K–N). Apoptosis was
severely increased in esco2 morphants (J, L, compared to wild type
in I, K), and independent of additional depletion of p53 (M, N).
(TIF)
Figure S5 Ingenuity pathway analysis of rad21 mutants
and esco2 morphants. Ingenuity pathway analysis (http://
www.ingenuity.com/products/pathways_analysis.html) of rad21
mutants (A) and esco2 morphants (B) at 1 dpf. Only a subset of
Rad21-regulated genes (e.g. those in the mcm cluster at the bottom
right) were also regulated by Esco2 depletion. The cut-off used for
the Rad21 experiment (A) is |unlogged fold change| $1.5 and
q(FDR-adjusted p) #0.01. The same graph is shown for the Esco2
experiment, but colored according the degree of RNA regulation
in the esco2 array (B). Fold changes are overlaid in both graphs.
Red, up-regulated in rad21 mutants or esco2 morphants, respec-
tively, relative to controls; green, down-regulated in rad21 mutants
or esco2 morphants, respectively, relative to controls.
(TIF)
Figure S6 Runx1 expression is normal in esco2 mor-
phants. Runx1 expression at 12–13 somites was normal in esco2
morphants (B, compared to wild type in A) compared to missing
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